AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
{{expandStatus?'Exit ':''}}Advanced Search
The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this sixth section of the report offers a comprehensive analysis of heart failure (HF) in China. HF is one of the most important cardiovascular disease in the 21st century. Its mortality is equivalent to that of cancer. It is an important public health problem that seriously affects the health of Chinese residents. In recent years, with the deepening of understanding, the change of treatment principles, the innovation of treatment methods and the update of treatment guidelines, the in-hospital mortality of HF patients has declined, and the long-term prognosis is also improving. However, there are still differences in the management level of HF among different hospitals in China. How to improve the standardized diagnosis and treatment level of HF in China remains an important challenge.
Gu DF, Huang GY, Wu XG, et al. [Epidemiological survey of heart failure in China and its prevalence]. Zhonghua Xin Xue Guan Bing Za Zhi 2003; 31: 6−9. [In Chinese].
Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail 2019; 21: 1329−1337.
Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circ Heart Fail 2021; 14: e008406.
Cheng KA, Wu N. [Retrospective investigation of hospitalized chronic heart failure cases in certain regions of China in 1980, 1990, and 2000]. Zhonghua Xin Xue Guan Bing Za Zhi 2002; 8: 5−9. [In Chinese].
Pei ZY, Zhao YS, Li JY, et al. [Fifteen-year changes in the etiology and short-term prognosis of hospitalized patients with chronic heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 5: 434−439. [In Chinese].
Zhang YH, Zhang J, Butler J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) registry. J Card Fail 2017; 23: 868−875.
Expert Working Group on Heart Failure, Expert Committee of the National Center for Cardiovascular Disease Medical Quality Control. [2020 China heart failure medical quality control report]. Zhonghua Xin Li Shuai Jie He Xin Ji Bing Za Zhi 2020; 04: 237−249. [In Chinese].
Li XY, Qin J, Liang X, et al. [Retrospective analysis of emergency rescue for 1198 patients with acute heart failure]. Zhonghua Lao Nian Xin Nao Xue Guan Bing Za Zhi 2012; 14: 1045−1047. [In Chinese].
Li CY, Jiang T, Wang WW, et al. [Analysis of the etiology and current treatment of heart failure patients in the emergency room]. Lin Chuang Xin Xue Guan Bing Za Zhi 2016; 32: 1009−1012. [In Chinese].
Li JL, Jiang C, Lai YW, et al. Association of on-admission anemia with 1-year mortality in patients hospitalized with acute heart failure: results from the HERO study. Front Ca rdiovasc Med 2022; 9: 856246.
Li Y, Sun XL, Qiu H, et al. Long-term outcomes and independent predictors of mortality in patients presenting to emergency departments with acute heart failure in Beijing: a multicenter cohort study with a 5-year follow-up. Chin Med J (Engl) 2021; 134: 1803−1811.
Liu XY, Yu HY, Pei JH, et al. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China. Heart Lung Circ 2014; 23: 818−826.
Yu SB, Zhao QY, Cui HY, et al. [Investigation and analysis of medication treatment for patients with chronic systolic heart failure]. Zhonghua Liu Xing Bing Xue Za Zhi 2012; 33: 229−233. [In Chinese].
Jiang H, Zhang HW, Zhou XH, et al. [Analysis of clinical characteristic and current treatment of chronic heart failure patients in different levels of hospitals in Xinjiang]. Zhong Guo Xun Huan Za Zhi 2015; 30: 1186−1190. [In Chinese].
Wang CH, Han S, Li Y, et al. Value of FT3/FT4 ratio in prognosis of patients with heart failure: a propensity-matched study. Front Cardiovasc Med 2022; 9: 859608.
Cai AP, Qiu WD, Zhou YL, et al. Clinical characteristics and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association Database-Heart Failure Center Registry. Eur J Heart Fail 2022; 24: 2048−2062.
Yuan HY, Han MH. [Analysis of drug treatment in 2106 cases of chronic heart failure]. Kun Ming Yi Ke Da Xue Xue Bao 2015; 36: 61−64. [In Chinese].
Wang M, Liu J, Liu J, et al. Association between early oral β-blocker therapy and in-hospital outcomes in patients with ST-elevation myocardial infarction with mild-moderate heart failure: findings from the CCC-ACS project. Fro nt Cardiovasc Med 2022; 9: 828614.
Wang B, Zhang LH, Hu S, et al. β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction. Eur Heart J Cardiovasc Pharmacother 2022; 8: 140−148.
Ye FM, Wang XF, Wu SL, et al. Sustained-release ivabradine hemisulfate in patients with systolic heart failure. J Am Coll Cardiol 2022; 80: 584−594.
Sun Y, Song S, Zhang Y, et al. Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure. ESC Heart Fail 2022; 9: 667−675.
Mao J, Zhang J, Lam CSP, et al. Qishenyiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial. ESC Heart Fail 2020; 7: 3881−3890.
Hung GU, Zou JG, He Z, et al. Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT. Ann Nu cl Med 2021; 35: 947−954.
Hu X, Qian ZY, Zou FW, et al. A mild dyssynchronous contraction pattern detected by SPECT myocardial perfusion imaging predicts super-response to cardiac resynchronization therapy. Front Cardiovasc Med 2022; 9: 906467.
Zhu MR, Wang YN, Cheng YF, et al. The value of non-invasive myocardial work indices derived from left ventricular pressure-strain loops in predicting the response to cardiac resynchronization therapy. Quant Imaging Med Surg 2021; 11: 1406−1420.
Varma N, Wang JA, Jaswal A, et al. CRT efficacy in “mid-range” QRS duration among Asians contrasted to non-Asians, and influence of height. JACC Clin Electrophysiol 2022; 8: 211−221.
Yang SW, Liu ZM, Li WR, et al. Validation of three European risk scores to predict long-term outcomes for patients receiving cardiac resynchronization therapy in an Asian population. J Cardiovasc Transl Res 2021; 14: 754−760.
He Z, Li DF, Cui C, et al. Predictive values of left ventricular mechanical dyssynchrony for CRT response in heart failure patients with different pathophysiology. J Nucl Ca rdiol 2022; 29: 2637−2648.
Zhang XW, Qian ZY, Tang HP, et al. A new method to recommend left ventricular lead positions for improved CRT volumetric response and long-term prognosis. J Nucl Cardiol 2021; 28: 672−684.
Hua BT, Pu LJ, Tian X, et al. Three-dimensional electroanatomical mapping guidelines for the selection of pacing site to achieve cardiac resynchronization therapy. Fro nt Cardiovasc Med 2022; 9: 843969.
Li J, Wang YG, Mai JT, et al. An electrographic AV optimization for the maximum integrative atrioventricular and ventricular resynchronization in CRT. BMC Cardiovasc Di sord 2021; 21: 288.
Hua W, Cai L, Su YG, et al. Acute hemodynamic impact of atrioventricular delay and left ventricular pacing vector programming in MultiPoint pacing. Pacing Clin Electr ophysiol 2022; 45: 649−657.
Huang WJ, Wu SJ, Vijayaraman P, et al. Cardiac resynchronization therapy in patients with nonischemic cardiomyopathy using left bundle branch pacing. JACC Clin El ectrophysiol 2020; 6: 849−858.
Zhang WW, Huang JJ, Qi YD, et al. Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block. Hea rt Rhythm 2019; 16: 1783−1790.
Li XF, Qiu CG, Xie RQ, et al. Left bundle branch area pacing delivery of cardiac resynchronization therapy and comparison with biventricular pacing. ESC Heart Fail 2020; 7: 1711−1722.
Chen XY, Ye Y, Wang ZK, et al. Cardiac resynchronization therapy via left bundle branch pacing vs optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre, observational study. Europace 2022; 24: 807−816.
Wang Y, Zhu HJ, Hou XF, et al. Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy. J Am Coll Cardiol 2022; 80: 1205−1216.
Gui Y, Ye LF, Wu LY, et al. Clinical outcomes associated with His-Purkinje system pacing vs biventricular pacing in cardiac resynchronization therapy: a meta-analysis. Front Cardiovasc Med 2022; 9: 707148.
Hua J, Chen Y, Yu JH, et al. Long-term outcomes of left bundle branch area pacing vs biventricular pacing in patients with heart failure and complete left bundle branch block. Heart Vessels 2022; 37: 1162−1174.
Liu W, Hu CQ, Wang YA, et al. Mechanical synchrony and myocardial work in heart failure patients with left bundle branch area pacing and comparison with biventricular pacing. Front Cardiovasc Med 2021; 8: 727611.
Zu LN, Zhang JM, Hang F, et al. Cardiac resynchronization performed by LBBaP-CRT in patients with cardiac insufficiency and left bundle branch block. Ann Noninvasive Electrocardiol 2021; 26: e12898.
Wu SJ, Su L, Vijayaraman P, et al. Left bundle branch pacing for cardiac resynchronization therapy: nonrandomized on-treatment comparison with His bundle pacing and biventricular pacing. Can J Cardiol 2021; 37: 319−328.
Vijayaraman P, Herweg B, Verma A, et al. Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: results from the International LBBAP Collaborative Study Group. Heart Rhy thm 2022; 19: 1272−1280.
Huang WJ, Wang SJ, Su L, et al. His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: a multicenter, randomized, crossover study–The ALTERNATIVE-AF Trial. Heart Rhythm 2022; 19: 1948−1955.
Zhang YH, Zhang RC, An T, et al. The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure. J Card Fail 2015; 21: 51−59.
Tian PC, Zhao XM, Huang LY, et al. Prognostic value of high-sensitivity cardiac troponin I in patients with non-ischemic heart failure: insights from China. ESC Heart Fail 2022; 9: 210−219.
Zou CH, Huang Y, Zhou Q, et al. [Long-term follow-up echocardiographic prognosis analysis of hospitalized patients with dilated cardiomyopathy]. Zhonghua Xinlishuai jie He Xinjibing Zazhi 2018; 2: 79−85. [In Chinese].
Chen SQ, Huang ZD, Liang Y, et al. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort. ESC Heart Fail 2022; 9: 2336−2347.
Zhang XX, Sun YX, Zhang YL, et al. Heart failure with midrange ejection fraction: prior left ventricular ejection fraction and prognosis. Front Cardiovasc Med 2021; 8: 697221.
He L, Dong ZJ, Du X, et al. Healthcare quality and mortality among patients hospitalized for heart failure by hospital level in Beijing, China. ESC Heart Fail 2021; 8: 1186−1194.
Zhang XG, Zhao J. [Guideline for rational use of drugs in chronic heart failure at primary care level]. Zhonghua Qu anke Yisheng Zazhi 2021; 20: 42−49. [In Chinese].
Chinese Medical Association, Chinese Society of Clinical Pharmacy, Chinese Medical Association Journal Editorial Board, et al. [Guideline for rational drug use in acute heart failure at primary care level]. Zhonghua Quanke Yisheng Za zhi 2021; 20: 34−41. [In Chinese].
Standardization Project Group of Clinical Application Guidelines for Traditional Chinese Medicine Treating Priority Diseases. [Clinical application guideline of traditional Chinese medicine for heart failure (2021)]. Zhongguo Zhong xiyi Jiehe Zazhi 2022; 3: 261−275. [In Chinese].
Zhang YH, Coats AJS, Zheng Z, et al. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020; 22: 941−956.
Liao YH, Yang JF, Zhang J, et al. [Expert consensus on the diagnosis and treatment of diastolic heart failure]. Linchu ang Xinxiangban Xue Zazhi 2020; 36: 1−10. [In Chinese].
Chinese Physician Association Heart Failure Specialty Committee, National Cardiovascular Disease Expert Committee Heart Failure Specialty Committee, Chinese Journal of Heart Failure and Cardiomyopathy Editorial Committee. [Expert consensus on ion management in Chinese heart failure patients]. Zhonghua Xinlixibing Zazhi 2020; 4: 16−31. [In Chinese].
Chinese Society of Cardiology Physicians Branch Structural Heart Disease Committee, Chinese Society of Cardiology Physicians Branch Heart Failure Specialty Committee, Chinese Society of Cardiology Surgeons Branch Structural Heart Disease Committee, et al. [Atrial septal shunt device therapy for heart failure with preserved ejection fraction: Chinese expert recognition and recommendations]. Zhongguo Jieruxinzangbing Xue Zazhi 2020; 28: 661−666. [In Chinese].
Chinese Association of Rehabilitation Medicine Cardiovascular Disease Prevention and Rehabilitation Professional Committee. [Chinese expert consensus on chronic heart failure cardiac rehabilitation]. Zhonghua Neike Zazhi 2020; 59: 942−952. [In Chinese].
Chinese Medical Association Geriatrics Branch Cardiovascular Disease Group, Elderly Chronic Heart Failure Diagnosis and Treatment Chinese Expert Consensus Writing Group. [Chinese expert consensus on diagnosis and treatment of chronic heart failure in elderly patients (2021)]. Zh onghua Laonian Yixue Zazhi 2021; 40: 550−561. [In Chinese].
Chinese Society of Cardiology Physicians Branch Heart Failure Study Group, China Heart Failure Center Alliance Expert Committee. [Chinese expert consensus on quality evaluation and control indicators for diagnosis and treatment of heart failure]. Zhongguo Yixue Qianyan Zazhi (Dianzi-Ban) 2021; 13: 52−62. [In Chinese].
Chinese Society of Cardiology Electrophysiology and Pacing Branch, Chinese Physician Association Arrhythmia Specialty Committee. [Chinese expert consensus on cardiac resynchronization therapy for chronic heart failure (2021 Revised Edition)]. Zhonghua Xinlvshichangbing Xue Zazhi 2021; 25: 465−478. [In Chinese].
Li XL. [Chinese expert consensus on management of patients with heart failure and preserved ejection fraction with hypertension]. Zhonghua Gaoxueya Zazhi 2021; 29: 612−617. [In Chinese].
Chinese Society of Cardiology Physicians Branch Heart Failure Study Group, Chinese Heart Failure Patient Hyperkalemia Management Expert Consensus Working Group. [Chinese expert consensus on hyperkalemia management in heart failure patients]. Zhonghua Yixue Zazhi 2021; 101: 3451−3458. [In Chinese].
Wang H, Li YY. [Chinese expert consensus on comprehensive management of exacerbated chronic heart failure patients 2022]. Zhongguo Xunhuan Zazhi 2022; 37: 215−225. [In Chinese].
Chinese Society of Cardiology, Chinese Society of Cardiology Physicians Branch. [Chinese expert consensus on management of chronic heart failure in women]. Zhonghua Xin Xueguanbing Zazhi 2022; 50: 653−661. [In Chinese].
Chinese Society of Cardiology, Chinese Journal of Cardiovascular Diseases Editorial Committee. [Chinese expert consensus on the use of angiotensin receptor-neprilysin inhibitors in heart failure patients]. Zhonghua Xin Xueguanbing Zazhi 2022; 50: 662−670. [In Chinese].
532
Views
104
Downloads
0
Crossref
0
Web of Science
0
Scopus
0
CSCD
Altmetrics
京公网安备11010802044758号